| Oct 4 |
TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting
|
| Aug 29 |
TScan Therapeutics to Participate in Upcoming Investor Conferences
|
| Aug 29 |
Director of TScan Therapeutics Barbara Klencke Buys 18% More Shares
|
| Aug 26 |
TScan Therapeutics: Speculative Buy With Near-Term Catalysts In Oncology
|
| Aug 13 |
Expert Outlook: TScan Therapeutics Through The Eyes Of 5 Analysts
|
| Aug 12 |
TScan Therapeutics GAAP EPS of -$0.28, revenue of $0.5M
|
| Aug 12 |
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Lags Revenue Estimates
|
| Aug 12 |
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
|
| Jun 24 |
TScan Therapeutics Decline Means Insider Profits Down To US$54k
|
| Jun 24 |
Strength Seen in Zealand Pharma AS (ZLDPF): Can Its 11.6% Jump Turn into More Strength?
|
